Shanmugam Muthusamy

Shanmugam Muthusamy

Active Director Director DIN 02684873
DIN 02684873 First appointment Jun 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 2 historical roles
Total affiliations 11 Since Jun 2009
Shareholding value •••• Premium profile

About Shanmugam Muthusamy

Data last updated:

Shanmugam Muthusamy is a Director at Saimirra Innopharm Private Limited (since 2012), Director at Nuray Chemicals Private Limited (since 2016) and Director at Scitus Pharma Services Private Limited (since 2017), and holds 6 more current directorships. The companies operate in Pharma and Energy. The 8 current companies with reported revenue have a combined latest revenue of ₹341 Cr; the largest is Saimirra Innopharm Private Limited at ₹133 Cr (FY 2025). Earlier, Shanmugam Muthusamy was a Director at Par Formulations Private Limited (2009–2012) and Director at Delvin Formulations Private Limited (from 2009).

DIN 02684873
Primary Designation Director
Industry Pharma
First Appointment 29 Jun 2009
Oldest Company Age 26 yrs
Largest company Saimirra Innopharm Private Limited · ₹133 Cr (FY 2025)
Combined revenue ₹341 Cr across 8 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saimirra Innopharm Private Limited U24232TN2000PTC044315
Director22 Oct 20122000₹133 Cr (FY 2025)Active
Nuray Chemicals Private Limited U24110TN2012PTC086320
Director20 Jul 20162012₹122 Cr (FY 2025)Active
Director26 Sep 20172017₹43.45 Cr (FY 2025)Active
Novitium Labs Private Limited U74999TN2016PTC112516
Director15 Sep 20162016₹33.80 Cr (FY 2025)Active
Esjay Pharma Private Limited U24290TN2022PTC155725
Director01 Jul 20242022₹3.90 Cr (FY 2024)Active
Sthree Chemicals Private Limited U24299TN2020PTC140109
Director10 Aug 20222020₹3.11 Cr (FY 2024)Active
Director06 Oct 20172015₹1.46 Cr (FY 2024)Active
Samy Solar Private Limited U40106TN2022PTC149069
Director07 Jan 20222022₹43,990 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Par Formulations Private Limited U33111TN1982PTC009602
Director29 Jun 20091982₹1,462 Cr (FY 2025)Active
Delvin Formulations Private Limited U24100TN2009PTC072376
Director24 Jul 20092009₹30.87 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Delvin Formulations Private Limited
Nuray Chemicals Private Limited
Saimirra Innopharm Private Limited
Sthree Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shanmugam Muthusamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanmugam Muthusamy

Shanmugam Muthusamy currently holds 9 directorships: Saimirra Innopharm Private Limited (Director, since 22 Oct 2012, revenue ₹133 Cr (FY 2025)); Nuray Chemicals Private Limited (Director, since 20 Jul 2016, revenue ₹122 Cr (FY 2025)); Scitus Pharma Services Private Limited (Director, since 26 Sep 2017, revenue ₹43.45 Cr (FY 2025)); Novitium Labs Private Limited (Director, since 15 Sep 2016, revenue ₹33.80 Cr (FY 2025)); Esjay Pharma Private Limited (Director, since 01 Jul 2024, revenue ₹3.90 Cr (FY 2024)); and 4 more.

Shanmugam Muthusamy was first appointed on 29 Jun 2009 as Director at Par Formulations Private Limited. The most recent appointment on record is 01 Jul 2024 at Esjay Pharma Private Limited.

The 8 current companies of Shanmugam Muthusamy that report revenue have a combined latest revenue of ₹341 Cr: Saimirra Innopharm Private Limited ₹133 Cr (FY 2025); Nuray Chemicals Private Limited ₹122 Cr (FY 2025); Scitus Pharma Services Private Limited ₹43.45 Cr (FY 2025); Novitium Labs Private Limited ₹33.80 Cr (FY 2025); Esjay Pharma Private Limited ₹3.90 Cr (FY 2024); and 3 more.

Shanmugam Muthusamy held 2 earlier board appointments: Par Formulations Private Limited (Director, 29 Jun 2009 to 17 Feb 2012); Delvin Formulations Private Limited (Director, from 24 Jul 2009).

The current boards of Shanmugam Muthusamy's companies include Abhishek Jain (Saimirra Innopharm Private Limited), Anushree Manmohan Chandak (Saimirra Innopharm Private Limited), Ayyavu Rajavel (Saimirra Innopharm Private Limited), Bernice Sugirtha (Saimirra Innopharm Private Limited), Jaganathan Jayaseelan (Saimirra Innopharm Private Limited), Thanigainathan Thirumurugan (Saimirra Innopharm Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available